Patent details

EP2481415 Title: Pharmaceutical compositions comprising Activin-ActRIIA antagonists

  • Data
  • Documents

Basic Information

Publication number:
EP2481415
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP111951513
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions comprising Activin-ActRIIA antagonists
French Title of Invention:
Compositions comprenant des antagonistes Activin-ActRIIA
German Title of Invention:
Zusammensetzungen enhaltend Activin-ActRIIA-Antagonisten
SPC Number:

Dates

Filing date:
01/02/2008
Grant date:
11/09/2019
EP Publication Date:
01/08/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2019
EP B1 Publication Date:
11/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2019
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/10/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Knopf, John
Address:
United States (US)

2

Name:
Kumar, Ravindra
Address:
United States (US)

3

Name:
Seehra, Jasbir
Address:
United States (US)

Priority

1

Priority Number:
90058007 P
Priority Date:
09/02/2007
Priority Country:
United States (US)

2

Priority Number:
93276207 P
Priority Date:
31/05/2007
Priority Country:
United States (US)

3

Priority Number:
93736507 P
Priority Date:
26/06/2007
Priority Country:
United States (US)

4

Priority Number:
52807 P
Priority Date:
25/10/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/18; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201937
Publication date:
11/09/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
10/01/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)